Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial-Reference-Cited by-同舟云学术

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

Published:2013-01-28 Issue:2 Volume:65 Page:314-324
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Oddis Chester V.,Reed Ann M.,Aggarwal Rohit,Rider Lisa G.,Ascherman Dana P.,Levesque Marc C.,Barohn Richard J.,Feldman Brian M.,Harris-Love Michael O.,Koontz Diane C.,Fertig Noreen,Kelley Stephanie S.,Pryber Sherrie L.,Miller Frederick W.,Rockette Howard E.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.37754/fullpdf

Reference33 articles.

1. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982;Oddis;J Rheumatol,1990

2. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies;Rider;JAMA,2011

3. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N Engl J Med,2004

4. Rituximab versus cyclophosphamide for ANCA-associated vasculitis;Stone;N Engl J Med,2010

5. Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry;Bader-Meunier;J Rheumatol,2011

Cited by 519 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Immune‐Mediated Necrotizing Myopathy;Arthritis Care & Research;2024-09-11

2. Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study;Journal of the American Academy of Dermatology;2024-09

3. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort;Clinical Rheumatology;2024-08-28

4. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27

5. Hypogammaglobulinemia and Infection Events in Patients with Autoimmune Diseases Treated with Rituximab: 10 Years Real-Life Experience;Journal of Clinical Immunology;2024-08-16